vs

Side-by-side financial comparison of Skyward Specialty Insurance Group, Inc. (SKWD) and U S PHYSICAL THERAPY INC (USPH). Click either name above to swap in a different company.

Skyward Specialty Insurance Group, Inc. is the larger business by last-quarter revenue ($385.6M vs $202.7M, roughly 1.9× U S PHYSICAL THERAPY INC). Skyward Specialty Insurance Group, Inc. runs the higher net margin — 11.2% vs 2.0%, a 9.2% gap on every dollar of revenue. On growth, Skyward Specialty Insurance Group, Inc. posted the faster year-over-year revenue change (26.7% vs 12.3%). Skyward Specialty Insurance Group, Inc. produced more free cash flow last quarter ($402.6M vs $21.0M). Over the past eight quarters, Skyward Specialty Insurance Group, Inc.'s revenue compounded faster (20.6% CAGR vs 14.1%).

Skyward Specialty Insurance Group, Inc. is a specialty property and casualty insurance provider offering tailored coverage solutions including commercial auto, general liability, professional indemnity, and specialty property policies. It primarily serves small-to-medium enterprises and niche industry segments across the United States, focusing on underwriting complex, hard-to-place risks for underserved client groups.

U.S. Physical Therapy Inc. operates hundreds of outpatient physical therapy clinics across the U.S. It offers rehabilitative care for patients recovering from injuries, surgeries, chronic pain and mobility impairments, plus specialized services including sports medicine and pediatric rehabilitation.

SKWD vs USPH — Head-to-Head

Bigger by revenue
SKWD
SKWD
1.9× larger
SKWD
$385.6M
$202.7M
USPH
Growing faster (revenue YoY)
SKWD
SKWD
+14.3% gap
SKWD
26.7%
12.3%
USPH
Higher net margin
SKWD
SKWD
9.2% more per $
SKWD
11.2%
2.0%
USPH
More free cash flow
SKWD
SKWD
$381.6M more FCF
SKWD
$402.6M
$21.0M
USPH
Faster 2-yr revenue CAGR
SKWD
SKWD
Annualised
SKWD
20.6%
14.1%
USPH

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
SKWD
SKWD
USPH
USPH
Revenue
$385.6M
$202.7M
Net Profit
$43.2M
$4.2M
Gross Margin
19.8%
Operating Margin
14.2%
8.3%
Net Margin
11.2%
2.0%
Revenue YoY
26.7%
12.3%
Net Profit YoY
200.1%
-55.1%
EPS (diluted)
$1.03
$-0.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SKWD
SKWD
USPH
USPH
Q4 25
$385.6M
$202.7M
Q3 25
$382.5M
$197.1M
Q2 25
$319.9M
$197.3M
Q1 25
$328.5M
$183.8M
Q4 24
$304.4M
$180.4M
Q3 24
$300.9M
$168.0M
Q2 24
$279.9M
$167.2M
Q1 24
$265.0M
$155.7M
Net Profit
SKWD
SKWD
USPH
USPH
Q4 25
$43.2M
$4.2M
Q3 25
$45.9M
$13.1M
Q2 25
$38.8M
$12.4M
Q1 25
$42.1M
$9.9M
Q4 24
$14.4M
$9.2M
Q3 24
$36.7M
$6.6M
Q2 24
$31.0M
$7.5M
Q1 24
$36.8M
$8.0M
Gross Margin
SKWD
SKWD
USPH
USPH
Q4 25
19.8%
Q3 25
18.7%
Q2 25
21.1%
Q1 25
16.9%
Q4 24
18.0%
Q3 24
17.3%
Q2 24
20.3%
Q1 24
18.2%
Operating Margin
SKWD
SKWD
USPH
USPH
Q4 25
14.2%
8.3%
Q3 25
15.8%
12.8%
Q2 25
15.6%
12.6%
Q1 25
15.7%
10.7%
Q4 24
6.1%
10.9%
Q3 24
15.6%
7.6%
Q2 24
14.4%
9.3%
Q1 24
17.7%
9.6%
Net Margin
SKWD
SKWD
USPH
USPH
Q4 25
11.2%
2.0%
Q3 25
12.0%
6.7%
Q2 25
12.1%
6.3%
Q1 25
12.8%
5.4%
Q4 24
4.7%
5.1%
Q3 24
12.2%
3.9%
Q2 24
11.1%
4.5%
Q1 24
13.9%
5.2%
EPS (diluted)
SKWD
SKWD
USPH
USPH
Q4 25
$1.03
$-0.44
Q3 25
$1.10
$0.48
Q2 25
$0.93
$0.58
Q1 25
$1.01
$0.80
Q4 24
$0.33
$0.52
Q3 24
$0.89
$0.39
Q2 24
$0.75
$0.47
Q1 24
$0.90
$0.46

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SKWD
SKWD
USPH
USPH
Cash + ST InvestmentsLiquidity on hand
$168.5M
$35.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.0B
$476.4M
Total Assets
$4.8B
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SKWD
SKWD
USPH
USPH
Q4 25
$168.5M
$35.6M
Q3 25
$160.1M
$31.1M
Q2 25
$136.6M
$34.1M
Q1 25
$112.9M
$39.2M
Q4 24
$121.6M
$41.4M
Q3 24
$105.6M
$117.0M
Q2 24
$73.0M
$112.9M
Q1 24
$85.1M
$132.3M
Stockholders' Equity
SKWD
SKWD
USPH
USPH
Q4 25
$1.0B
$476.4M
Q3 25
$961.4M
$503.6M
Q2 25
$899.9M
$500.8M
Q1 25
$850.7M
$497.3M
Q4 24
$794.0M
$488.9M
Q3 24
$797.5M
$482.8M
Q2 24
$723.6M
$484.6M
Q1 24
$692.3M
$479.8M
Total Assets
SKWD
SKWD
USPH
USPH
Q4 25
$4.8B
$1.2B
Q3 25
$4.6B
$1.2B
Q2 25
$4.3B
$1.2B
Q1 25
$4.0B
$1.2B
Q4 24
$3.7B
$1.2B
Q3 24
$3.6B
$1.0B
Q2 24
$3.4B
$1.0B
Q1 24
$3.2B
$1.0B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SKWD
SKWD
USPH
USPH
Operating Cash FlowLast quarter
$408.1M
$24.9M
Free Cash FlowOCF − Capex
$402.6M
$21.0M
FCF MarginFCF / Revenue
104.4%
10.4%
Capex IntensityCapex / Revenue
1.4%
1.9%
Cash ConversionOCF / Net Profit
9.44×
6.00×
TTM Free Cash FlowTrailing 4 quarters
$755.2M
$61.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SKWD
SKWD
USPH
USPH
Q4 25
$408.1M
$24.9M
Q3 25
$171.4M
$19.9M
Q2 25
$88.2M
$34.9M
Q1 25
$96.8M
$-4.7M
Q4 24
$305.1M
$19.4M
Q3 24
$168.0M
$22.1M
Q2 24
$21.0M
$29.0M
Q1 24
$94.3M
$4.4M
Free Cash Flow
SKWD
SKWD
USPH
USPH
Q4 25
$402.6M
$21.0M
Q3 25
$168.9M
$15.6M
Q2 25
$87.1M
$31.6M
Q1 25
$96.6M
$-7.3M
Q4 24
$300.9M
$16.9M
Q3 24
$167.6M
$19.6M
Q2 24
$18.4M
$26.7M
Q1 24
$94.0M
$2.6M
FCF Margin
SKWD
SKWD
USPH
USPH
Q4 25
104.4%
10.4%
Q3 25
44.2%
7.9%
Q2 25
27.2%
16.0%
Q1 25
29.4%
-3.9%
Q4 24
98.8%
9.4%
Q3 24
55.7%
11.7%
Q2 24
6.6%
15.9%
Q1 24
35.5%
1.7%
Capex Intensity
SKWD
SKWD
USPH
USPH
Q4 25
1.4%
1.9%
Q3 25
0.6%
2.2%
Q2 25
0.3%
1.6%
Q1 25
0.1%
1.4%
Q4 24
1.4%
1.4%
Q3 24
0.1%
1.5%
Q2 24
0.9%
1.4%
Q1 24
0.1%
1.2%
Cash Conversion
SKWD
SKWD
USPH
USPH
Q4 25
9.44×
6.00×
Q3 25
3.73×
1.52×
Q2 25
2.27×
2.81×
Q1 25
2.30×
-0.47×
Q4 24
21.18×
2.10×
Q3 24
4.58×
3.34×
Q2 24
0.68×
3.86×
Q1 24
2.56×
0.55×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SKWD
SKWD

Segment breakdown not available.

USPH
USPH

Net Patient Revenues$169.7M84%
Industrial Injury Prevention Services Revenues$28.9M14%
Management Contract Revenues$2.3M1%

Related Comparisons